“a slight trend”

However, there was a slight trend toward faster contraction in injured muscles compared to uninjured (1.15‐fold) and in aged versus young mice (1.1‐fold, Figure 5f ).

Moreover, a slight trend for decreased latencies across the 3 test trials was observed in rats receiving rolipram and anisomycin, although this did not reach statistical significance.

A slight trend of decreasing hardness with increasing rate may have existed, but was within the uncertainty (scatter bars) of the experiments.

In contrast, H3-G34K showed a slight trend toward transcriptional repression of ST regions (in particular on the left end of chromosome II).

The APTH (Ambulatory Blood Pressure and Treatment of Hypertension) trial in 1997, the THOP (Treatment of Hypertension Based on Home or Office Blood Pressure) trial in 2004, and the HOMERUS (Home versus Office MEasurements, Reduction of Unnecessary treatment Study) trial in 2007 failed to show any significant difference in surrogate endpoint outcomes, such as left ventricular mass changes, with a slight trend toward lower medication costs balanced by the higher costs of the ambulatory and home blood pressure equipment. 43 - 45 Moreover, the idea of developing an ideal trial for absolute evidence becomes a difficult task, as noted by the Agency for Healthcare Research and Quality (AHRQ), which has estimated that a sample size of 26 000 to 57 000 patients would be needed to achieve a 10% relative risk reduction in a 10-year trial comparing office versus ambulatory blood pressure monitoring. 46 Such a trial is unlikely to happen anytime soon.

However, a slight trend toward improvement was observed in the inner layers of certain areas, although this was not consistent with the findings from retinal whole-mount specimens and ERG waveforms.

Regarding a potential correlation between SEC62 expression and response to treatment according to RECIST 1.1 criteria, no significant difference in SEC62 levels was seen between patients with complete remission (CR), partial remission (PR), stable disease (SD), and progressive disease (PD), with only a slight trend towards lower SEC62 levels in CR patients compared to non-CR patients (PR + SD + PD; Figure 1 F).

In addition, there was a slight trend for higher EMH in prostate cancer patients associated with higher income.

Data analyzed by only maternal age showed no differences in the quality of day 3 embryos, a slight trend toward higher blastulation rates in younger patients compared with advanced maternal age, and no difference in the number of embryos biopsied.

As shown in Figure 10 , we observed no significant difference between WT and Q175 mice in GPe neuron labeling intensity or in the spatial density of neurons labeled for GABAA‐α1 at 2, 6, 12, or 18 months of age by ISHH, although a slight trend toward increased signal intensity was seen at 12 months.

In the present report, it was not elevated in chronic SCI patients, although a slight trend toward increased levels was discerned.

When studies were ranked from high glucocorticoid resistance in patients to low glucocorticoid resistance using the “glucocorticoid resistance index,” there was a slight trend for studies that reported high glucocorticoid resistance in patients to produce larger effect sizes (based on 170 patients and 187 controls; Figure 4A ).

When stratified by treatment arm, a slight trend towards higher AUC 0–12m values was observed for cured patients compared to noncured patients in both the 200- and 300-mg fosravuconazole cohorts ( Figure 4 A ).

However, during treatment, no effects on the degree of fatigue were observed, although a slight trend was observed after four weeks of treatment (Figure 4 ).

We observed little if any difference in Tie2 expression between RA and PsA PB-derived macrophages, and only a slight trend towards increased sensitivity to Ang-2 in PsA, indicating that systemic disease influences did not overtly impact on myeloid Tie2 signalling.

Furthermore, the AFE and AFFE were estimated at 1.48 and 1.63, respectively, for the predicted plasma exposure, suggesting a slight trend of overprediction, while remaining within the requirements for satisfactory model performance.

Further stratification between deprivation quintile and age indicated a slight trend in the prevalence between deprivation groups by age categories ( figure 1B ).

In MDA-MB-231, all treatments prevented colony growth to a similar extent under pre-menopausal conditions, with a slight trend towards JSH-23 treatment alone having the greatest effect on reducing colony growth, however this did not reach statistical significance ( Figure 4 I,J,Q).

Here, in contrast, we observed a slight trend that the larger number of EC parameters selected for the age prediction positively contributed to prediction quality.

The GF-axis values were maintained at ∼11° for both WT and A108G regardless of the protonation state of His161, indicating that the F-form was maintained during the MD simulation, although there was a slight trend from the F-form to the G-form transition ( Figures 5A–C ).

Only one study described a slight trend toward worse lymphoma-specific survival in PET+ diffuse patients than in PET+ focal ones [ 41 ].

In addition, there were weaker effects of year of collection (with a slight trend for increasing MIC over time); for serotype (with non-disease-associated serotypes tending to have higher MIC); and for host disease status (with non-clinical isolates having higher MIC) (Table 1 (B)).

Response rates and overall survival were evaluated using pooled statistical analysis.The pooled response data in 2281 patients showed a slight trend favouring the combination therapy, although this did not reach statistical significance (odds ratio (OR), 0.79; 95% confidence interval (CI), 0.60–1.05; p =0.10).

Here, we observed only a slight trend towards a better outcome in patients with L3SMI/MMA values above the cohort’s median (76.79 mm 2 /cm and 34.55 HU, Figure 3 A and B).

Overall, there was a slight trend for δ 15 N to increase 0.06 for every increase in one nestling fledged from each nest.